Key player · Company profile

F. Hoffmann-La Roche Ltd

Named as a key player in 297 of our reports, across 33 regions and countries.

Fastest-growing markets they play in

2023–2033 CAGR · estimates

  1. 1Digital diabetes care (India) 22.3%
  2. 2Brain Cancer Diagnostic (India) 16.6%
  3. 3Breast Cancer Diagnostic (India) 10.8%
  4. 4Bone Cancer Diagnostic (India) 10.4%
  5. 5Alzheimers Dignostic (India) 9.9%
  6. 6Alzheimer Drugs (India) 9.8%
  7. 7HIV Drugs (India) 8.8%
  8. 8Asthma & COPD Drugs (India) 7%

Where they show up

  • Healthcare Services165
  • Pharmaceuticals99
  • Digital Health33

Geographies

F. Hoffmann-La Roche Ltd's markets

Markets where F. Hoffmann-La Roche Ltd is a key player, with the world market size
MarketCategoryWorld 2023CAGR
Asthma & COPD Drugs Pharmaceuticals$49.5 Bn4%
HIV Drugs Pharmaceuticals$30 Bn5.8%
Digital diabetes care Digital Health$12.8 Bn19.3%
Breast Cancer Diagnostic Healthcare Services$4.1 Bn7.8%
Alzheimers Dignostic Healthcare Services$2.1 Bn6.9%
Brain Cancer Diagnostic Healthcare Services$1.5 Bn13.6%
Bone Cancer Diagnostic Healthcare Services$1.1 Bn7.4%
Alopecia areata Healthcare Services––
Alzheimer Drugs Pharmaceuticals––

Companies they compete with most

Named as key players in the same markets as F. Hoffmann-La Roche Ltd (number of shared markets).

Abbott Laboratories4 shared markets AbbVie Inc.4 shared markets Johnson & Johnson4 shared markets Merck & Co., Inc.4 shared markets Eli Lilly and Company3 shared markets GlaxoSmithKline plc3 shared markets Novartis AG3 shared markets Siemens Healthineers3 shared markets

Recent reports naming F. Hoffmann-La Roche Ltd

Search all reports for F. Hoffmann-La Roche Ltd All companies